Research interests include Colorectal and Anal Carcinomas, Colorectal Cancer Surgical Treatments, Cancer Immunotherapy and Biomarkers, and Genetic factors in colorectal cancer.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
British journal of surgery2023cited by 60position: middledoi